Saratov JOURNAL of Medical and Scientific Research

Тhe efficiency of complex treatment of different variants of myasthenia gravis

Year: 2018, volume 14 Issue: №1 Pages: 145-148
Heading: Neurology Article type: Original article
Authors: Lapshina O.V., Antipenko Е.А., Gustov A.V.
Organization: Privolzhskiy Research Medical University

The aim: to evaluate the effect of complex restorative treatment on clinical manifestations and the state of oxidative homeostasis in patients with different variants of myasthenia gravis. Material and Methods. The analysis of indicators of biochemiluminescence, muscle strength according to the scales QMGS and MG-ADL, instrumental methods of research (ENMG and respiratory function) before and after treatment in 117 patients with myasthenia gravis is carried out. For comparative analysis of independent samples was used Mann — Whitney U-test, and for paired comparisons was used the Wilcoxon test. Results. The dynamics of oxidative homeostasis, clinical picture, indicators of instrumental methods of research (ENMG, respiratory function) in patients with myasthenia gravis, without thymoma and underwent thymectomy on the background of complex treatment with the use of antioxidant therapy is presented. In all studied groups against the background of complex treatment with application of antioxidant therapy increase in activity of antioxidant protection of organism and decrease in activity of free radical oxidation that correlates with clinical improvement in all groups of patients is noted. Conclusion. The use of antioxidant therapy in complex rehabilitation of patients with myasthenia gravis is pathogenetically justified, especially in patients without thymoma.

1 Sanadze AG. Myasthenia gravis and myasthenic syndromes. Moscow: LitTerra, 2012; 255 p.
2 Romanova TV. Optimisation of diagnostic and therapeutic care for patients with myasthenia gravis (analysis of the experience of the regional myasthenic center). Practical medicine 2012; 57 (2): 153-157
3 Shkol'nikVM, Kal'busAI, Baranenko AN, et al. Myasthenia gravis: modern approaches to diagnosis and treatment. Ukranian neurological journal 2014; 31 (2): 12-17 (2): 12-17
4 Романова Т. В. Оптимизация подходов к прогнозированию течения и лечению миастении в условиях регионального специализированного центра: дис. ... д-ра мед. наук. Самара, 2016; 296 с.
5 Смолин A.M. Миастения: варианты клинического течения, дифференцированное лечение и качество жизни пациентов: дис. ... канд. мед. наук. Иркутск, 2015; 127 с.
6 Vasil'eva ЕМ, Bakanov Ml. Biochemical changes in neurological pathology. Biomedical chemistry 2005; (6): 581-602
7 Smolin Al. Modern aspects of clinic and diagnostic of myasthenia gravis. Syberian Medical Journal 2013; (3): 14
8 Hoffmann S, Ramm J, Grittner U, et al. Fatigue in myasthenia gravis: risk factors and impact on quality of life. Brain and Behavior 2016; 6 (10): 1-8
9 Koopman WJ, LeBlanc N, Fowler S, et al. Hope, coping, and quality of life in adults with myasthenia gravis. Canadian Journal of Neuroscience Nursing 2016; 38 (1): 56-64
10 Sieb JP Myasthenia gravis: an update for the clinician. Clinical and Experimental Immunology 2014; 175 (3): 408-418
11 Maslennikov OV, Kontorshhikova KN. Practical ozone therapy: a Handbook. N. Novgorod: Vektor — TiS, 2003; 52 p.
12 Gustov AV, Kontorshhikova KN, Potehina JuP Ozone therapy in neurology. N. Novgorod: Izdatel'stvo NizhGMA, 2012; 192 p.
13 Zanardi I, Borrelli Е, Vaiacchi G, et al. Ozone: a multifaceted molecule with unexpected therapeutic activity. Current Medicinal Chemistry 2016; 23 (4): 304-314
14 Bocci V, Zanardi I, Travagli V Ozone: a new therapeutic agent in vascular diseases. American Journal of Cardiovascular Drugs 2011; 11 (2): 73-82.

2018_01-1_145-148.pdf238.22 KB

No votes yet